Cargando…
CD44 as a potential diagnostic tumor marker
CD44 is a cellular protein that has been intensively studied in relation to carcinogenesis over the last decade. It is altered during inflammatory responses and cellular malfunctioning during tumor progression. Tumors of epithelial origin express CD44 in multiple isoforms called variants; some isofo...
Autor principal: | Basakran, Nawwaf S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Saudi Medical Journal
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381009/ https://www.ncbi.nlm.nih.gov/pubmed/25737167 http://dx.doi.org/10.15537/smj.2015.3.9622 |
Ejemplares similares
-
CD44 as a tumor biomarker and therapeutic target
por: Xu, Hanxiao, et al.
Publicado: (2020) -
Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
por: Chaudhry, Gul-e-Saba, et al.
Publicado: (2021) -
Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
por: Jaggupilli, Appalaraju, et al.
Publicado: (2012) -
Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer
por: Watanabe, Toru, et al.
Publicado: (2017) -
Scandium-44: Diagnostic Feasibility in Tumor-Related Angiogenesis
por: Trencsényi, György, et al.
Publicado: (2023)